Adrien Chavanne

Everyone's Back (Except Wall Street)

It's back-to-school season, and my breakfast chocolate drawer is desperately empty. No, really, this morning is off to a bleak start. Financial markets, too, should be treading water today in the absence of Wall Street.

01 September 2025 at 04:29 pm AEST

Big contracts and AI make Softcat a Top Cat

The British provider of IT services, hardware, and software continues to surprise its investors after raising its annual targets for the third time in six months.

29 August 2025 at 05:08 pm AEST

Keurig Dr Pepper: a caffeinated gamble that has Wall Street on edge

The owner of Dr Pepper, 7Up, and Schweppes sodas has fallen sharply over the last two trading sessions in New York following the announcement of the $18.4bn acquisition of Dutch coffee and tea giant JDE Peet's. Investors are frowning on the complexity of the deal and the risk it poses to the American company's already fragile structure. Financed by massive debt, this will delay the medium-term debt reduction targets promised by management.

27 August 2025 at 11:47 pm AEST

Can Apple still reinvent the future?

With growth stalling since Covid, Apple needs to innovate again and take risks to appeal to both consumers and investors.

26 August 2025 at 07:42 pm AEST

Valneva: the return of biotech euphoria?

The Franco-Austrian laboratory, which generated a lot of excitement during the Covid-19 pandemic with its attempt to develop a vaccine, has been staging a strong rebound since the beginning of last month.

13 August 2025 at 05:07 pm AEST

Monster Beverage: energy that reassures

The US energy drink specialist surprised with better-than-expected quarterly results and summer sales momentum that supports analysts' optimistic forecasts.

12 August 2025 at 05:34 pm AEST

Bechtle is back on track

Bechtle is a German group specializing in the distribution of IT hardware, software, and IT services for businesses and public administrations. It operates through a large network of local agencies and online platforms, enabling it to combine a strong local presence with large-scale distribution capabilities in Europe, although Germany remains its main market, accounting for 62% of its revenue.

12 August 2025 at 12:49 am AEST

Sandoz has significant clinical visibility

After a convincing first half, the Swiss generic and biosimilar drugs company is continuing its strong performance of recent weeks, with the stock rising 12% on Thursday.

08 August 2025 at 05:48 pm AEST

Is Gartner in critical danger?

This US company specializes in creating and providing exclusive content, data, benchmarks, and strategic analysis, accessible by subscription. This research activity accounts for nearly 80% of its revenue. The rest comes from conferences and consulting. The stock plunged 27% yesterday.

07 August 2025 at 12:45 am AEST

Trump 1 - Powell 0?

With the CAC 40 tumbling 2.9% and the Nasdaq Composite sliding 2.2%, Friday's session left a clear mark. Yet the latest US employment data has reshuffled the monetary policy deck, triggering both a mini-market frenzy and a full-blown political storm. Will the Fed's rate cuts, so eagerly awaited by investors, outweigh the chaos unleashed by the current tariff offensive? That is the question of the summer.

04 August 2025 at 04:15 pm AEST

Ferrari: a difficult stall to understand?

The Italian brand took a dive yesterday after presenting its H results, and its stock continued falling today. There is little to justify such a sharp drop, which brings the share 1price back to where it was a year ago.

01 August 2025 at 09:48 pm AEST

The List, Episode 2

It seems someone reminded a few absent-minded investors yesterday that a fresh wave of tariffs is looming in August. That cast a chill over markets for the final trading session of July. The Trump administration is hitting hard at major trading partners, including Brazil, Canada, India and Switzerland.

01 August 2025 at 04:26 pm AEST

Align Technology: Shareholders are losing patience

The US dental appliance specialist's shares fell over 30% in pre-market trading on Wall Street after the company announced a disappointing outlook.

01 July 2025 at 12:04 am AEST

Powell Takes the Front Line

The US Federal Reserve struck a notably firmer tone than expected yesterday, dampening prospects of a September rate cut. Enough to unnerve investors - though the staggering results from Microsoft and Meta provided some welcome warmth to an otherwise chilly market mood. Meanwhile, tariffs and corporate earnings are raining down.

31 July 2025 at 04:08 pm AEST

Chipotle: is the tide turning?

The burrito restaurant chain took a heavy hit on the stockmarket last week after lowering its annual targets. However, this year could mark a turning point in the stockmarket success story that Chipotle has offered its shareholders for many years. Visibility on the stock has probably never been this low since 2015.

30 July 2025 at 05:03 pm AEST

The Heavyweights Step In

No, this is not about lorries or overweight individuals, but rather about the corporate earnings season reaching its climax. On the agenda: a deluge of figures from both Europe and the United States, where Big Tech is set to dominate the stage in the hours ahead. To add a touch of drama, today also brings a Federal Reserve interest rate decision, Sino-American trade discussions - and even a tsunami.

30 July 2025 at 04:13 pm AEST

Novo Nordisk falters once again

In the middle of trading, Novo Nordisk shares are down over 20% after another reduction in its outlook for the year - the second in just a few months. Considered an impregnable fortress until June 2024, due to its duopoly, alongside Eli Lilly, in the field of anti-obesity treatments, the Danish group has suffered a series of setbacks. Its return to reality has been brutal: two-thirds of the company's value has gone up in smoke since the stock peaked.

29 July 2025 at 11:39 pm AEST

All That for This!

The white smoke rising from the US-Europe trade agreement failed to spark any great enthusiasm among investors. They swiftly moved on, as the weekly calendar is packed with plenty of other events worth their attention-not least two central bank meetings, hundreds of corporate earnings reports, and a hearty serving of macroeconomic indicators.

29 July 2025 at 04:13 pm AEST

Yet another setback for Puma

On Friday, the German sports brand announced that it expects to post a loss for the current fiscal year. Just a few months ago, investors were expecting a profit of EUR500m. This is the third profit warning since the beginning of the year… and the market is losing patience.

26 July 2025 at 12:57 am AEST

The Narrative Shifts, But the Journey Remains Unchanged

New session, same story. For the fourth consecutive time, the S&P 500 closed in positive territory, setting yet another record, buoyed by strong momentum on the trade front and Alphabet's robust earnings. Despite ongoing economic uncertainty, investors continue to find a storyline to cling to. In Europe, indices ended the day mixed, with several companies punished for disappointing results

25 July 2025 at 04:34 pm AEST

STMicroelectronics takes another hit

On Thursday, the chip manufacturer's share price fell by more than 15%. This is the biggest daily drop in a year. The publication of the results did not reassure investors.

25 July 2025 at 12:01 am AEST